Indexed In
- Open J Gate
- Genamics JournalSeek
- China National Knowledge Infrastructure (CNKI)
- Ulrich's Periodicals Directory
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Publons
- Google Scholar
Useful Links
Share This Page
Journal Flyer
Open Access Journals
- Agri and Aquaculture
- Biochemistry
- Bioinformatics & Systems Biology
- Business & Management
- Chemistry
- Clinical Sciences
- Engineering
- Food & Nutrition
- General Science
- Genetics & Molecular Biology
- Immunology & Microbiology
- Medical Sciences
- Neuroscience & Psychology
- Nursing & Health Care
- Pharmaceutical Sciences
Priyanshi Sharma
Department of Pharmacology, HIMT College of Pharmacy, Uttar Pradesh, India
Publications
-
Review Article
A Systemic Review on Aducanumab and Lecanamab in the Development of ARIA in Alzheimer's Disease
Author(s): Ankit Verma*, Roshi and Priyanshi Sharma
Alzheimer's is a condition of neurodegenerative disease, which caused cognitive and memory loss in the patient. The condition usually progresses in those over 65, and it causes dementia to develop along with memory loss and impairments in cognitive behavior. By 2050, there will be 113 million cases of dementia worldwide, up from the 50 million cases there were in 2010. Amyloid plaques and neurofibrillary tangles are the major cause of AD. Formation of Aβ associated with the conversion of APP protein into Aβ through γ-secretase enzyme and formation of neurotangillary fibre are associated with hyperphosphorylation of tau protein. Disease modifying therapy like aducanumab, bapineuzumab, gantenerumab, donanemab, crenezumab, solanezumab and lecanamab are developed. It is believed that these Anti Aβ antibodies are very significantly reduce the level of A&be.. View more»